UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

British journal of pharmacology, 2017-06, Vol.174 (11), p.1349-1365

2017

Volltextzugriff (PDF)

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

Progress in lipid research, 2016-04, Vol.62, p.107-128

2016

Volltextzugriff (PDF)

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review

International journal of molecular sciences, 2020-12, Vol.21 (24), p.9526

2020

Volltextzugriff (PDF)

Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

British journal of pharmacology, 2011-08, Vol.163 (7), p.1479-1494

2011

Volltextzugriff (PDF)

N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities

Biochimie, 2010-06, Vol.92 (6), p.724-727

2010

Volltextzugriff (PDF)

The anti‐inflammatory mediator palmitoylethanolamide enhances the levels of 2‐arachidonoyl‐glycerol and potentiates its actions at TRPV1 cation channels

British journal of pharmacology, 2016-04, Vol.173 (7), p.1154-1162

2016

Volltextzugriff (PDF)

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion

Neurobiology of disease, 2019-05, Vol.125, p.77-91

2019

Volltextzugriff (PDF)

Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti‐inflammatory agent

British journal of pharmacology, 2015-01, Vol.172 (1), p.142-158

2015

Volltextzugriff (PDF)

Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons

Proceedings of the National Academy of Sciences - PNAS, 2013-06, Vol.110 (24), p.E2229-E2238

2013

Volltextzugriff (PDF)

Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats

PloS one, 2011-09, Vol.6 (9), p.e25565

2011

Volltextzugriff (PDF)

Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia

Frontiers in neurology, 2017-06, Vol.8, p.233-233

2017

Volltextzugriff (PDF)

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

Journal of neuroinflammation, 2019-12, Vol.16 (1), p.274-274, Article 274

2019

Volltextzugriff (PDF)

Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats

The Journal of neuroscience, 2012-10, Vol.32 (43), p.14899-14908

2012

Volltextzugriff (PDF)

Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint

Animals (Basel), 2022-01, Vol.12 (3), p.348

2022

Volltextzugriff (PDF)

Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feeding

British journal of pharmacology, 2009-09, Vol.158 (2), p.451-461

2009

Volltextzugriff (PDF)

endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kᵥ7 channels

Proceedings of the National Academy of Sciences - PNAS, 2014-06, Vol.111 (24), p.E2472-E2481

2014

Volltextzugriff (PDF)

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism

PloS one, 2013-04, Vol.8 (4), p.e60040-e60040

2013

Volltextzugriff (PDF)

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect

Frontiers in pharmacology, 2018-03, Vol.9, p.249

2018

Volltextzugriff (PDF)

Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System

Science (American Association for the Advancement of Science), 2007-06, Vol.316 (5830), p.1494-1497

2007

Volltextzugriff (PDF)

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

Neuropharmacology, 2007-02, Vol.52 (2), p.415-422

2007

Volltextzugriff (PDF)

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

Molecular and cellular endocrinology, 2008-04, Vol.286 (1), p.S66-S78

2008

Volltextzugriff (PDF)

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors

The Journal of pharmacology and experimental therapeutics, 2006-03, Vol.316 (3), p.969-982

2006

Volltextzugriff (PDF)

Endocannabinoid chemical biology: a tool for the development of novel therapies

Current opinion in chemical biology, 2009-06, Vol.13 (3), p.309-320

2009

Volltextzugriff (PDF)

Corrigendum: Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal antihyperalgesic effect

Frontiers in pharmacology, 2024, Vol.15, p.1441203

2024

Volltextzugriff (PDF)

2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation

Frontiers in pharmacology, 2017-05, Vol.8, p.308-308

2017

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(99)
Life Sciences & Biomedicine
(85)
Animals
(73)
Endocannabinoids
(58)
Male
(49)
Humans
(41)
Mice
(35)
Cannabinoid Receptor Modulators - Metabolism
(29)
Pharmacology & Pharmacy
(29)
Neurosciences
(26)
Rats
(26)
Arachidonic Acids - Metabolism
(24)
Neurosciences & Neurology
(24)
Female
(23)
Biological And Medical Sciences
(22)
Inflammation
(22)
Glycerides - Metabolism
(21)
Medical Sciences
(21)
Anandamide
(20)
Palmitoylethanolamide
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review

Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities

The anti‐inflammatory mediator palmitoylethanolamide enhances the levels of 2‐arachidonoyl‐glycerol and potentiates its actions at TRPV1 cation channels

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion

Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti‐inflammatory agent

Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons

Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats

Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity

Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats

Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint

Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feeding

endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kᵥ7 channels

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism

Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect

Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors

Endocannabinoid chemical biology: a tool for the development of novel therapies

Corrigendum: Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal antihyperalgesic effect

2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation

Suchergebnisse filtern